Abstract

IntroductionReade, Centre for Rehabilitation and Rheumatology, Amsterdam, the Netherlands, started an outpatient clinic for people with knee and/or hip osteoarthritis (OA) in 2009. The main reason behind this is that...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
FRI0584-HPR Satisfaction and quality of hip and knee oa management in norwegian primary health care. is the glass half full or half empty?
G Grønhaug ... N Østerås
Annals of the Rheumatic Diseases | VOL. 72
G Grønhaug, et. al.G Grønhaug ... N Østerås
01 Jun 2013
Psychometric properties of the French translation of the reduced KOOS and HOOS (KOOS-PS and HOOS-PS)
P Ornetti ... J.F Maillefert
Osteoarthritis and Cartilage | VOL. 17
P Ornetti, et. al.P Ornetti ... J.F Maillefert
26 Jun 2009
Comparison of education, home exercise and supervised exercise in patients with knee and hip osteoarthritis: data from the BOA registry
A Dell'Isola ... L Dahlberg
Osteoarthritis and Cartilage | VOL. 27
A Dell'Isola, et. al.A Dell'Isola ... L Dahlberg
01 Apr 2019
Is there an increased risk of falls and fractures in people with early diagnosed hip and knee osteoarthritis? Data from the Osteoarthritis Initiative.
Toby O Smith ... Matthew Pearson
International Journal of Rheumatic Diseases | VOL. 21
Toby O Smith, et. al.Toby O Smith ... Matthew Pearson
06 May 2016
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
Jinjing Liu ... Xiaofeng Zeng
Annals of the Rheumatic Diseases | VOL. -
Jinjing Liu, et. al.Jinjing Liu ... Xiaofeng Zeng
27 Nov 2024
CD-19 CAR-T cells for polyrefractory rheumatoid arthritis
Merav Lidar ... Abraham Avigdor
Annals of the Rheumatic Diseases | VOL. -
Merav Lidar, et. al.Merav Lidar ... Abraham Avigdor
27 Nov 2024
Correction: Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment
-
Annals of the Rheumatic Diseases | VOL. -
--
27 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.